Impairment of Common Mode Rejection by Mismatched Electrode Impedances: Quantitative Analysis

Diagnostic accuracy of microEEG: a miniature, wireless EEG device

Measuring the diagnostic accuracy (DA) of an EEG device is unconventional and complicated by imperfect interrater reliability. We sought to compare the DA of a miniature, wireless, battery-powered EEG device ("microEEG") to a reference EEG machine in emergency department (ED) patients with altered mental status (AMS). Two hundred twenty-five ED patients with AMS underwent 3 EEGs. Two EEGs, EEG1 (Nicolet Monitor, "reference") and EEG2 (microEEG) were recorded simultaneously with EEG cup electrodes using a signal splitter. The remaining study, EEG3, was recorded with microEEG using an electrode cap immediately before or after EEG1/EEG2. The official EEG1 interpretation was considered the gold standard (EEG1-GS). EEG1, 2, and 3 were de-identified and blindly interpreted by two independent readers. A generalized mixed linear model was used to estimate the sensitivity and specificity of these interpretations relative to EEG1-GS and to compute a diagnostic odds ratio (DOR). Seventy-nine percent of EEG1-GS were abnormal. Neither the DOR nor the κf representing interrater reliabilities differed significantly between EEG1, EEG2, and EEG3. The mean setup time was 27 min for EEG1/EEG2 and 12 min for EEG3. The mean electrode impedance of EEG3 recordings was 12.6 kΩ (SD: 31.9 kΩ). The diagnostic accuracy of microEEG was comparable to that of the reference system and was not reduced when the EEG electrodes had high and unbalanced impedances. A common practice with many scientific instruments, measurement of EEG device DA provides an independent and quantitative assessment of device performance.

Technical and clinical analysis of microEEG: a miniature wireless EEG device designed to record high-quality EEG in the emergency department

BACKGROUND

We describe and characterize the performance of microEEG compared to that of a commercially available and widely used clinical EEG machine. microEEG is a portable, battery-operated, wireless EEG device, developed by Bio-Signal Group to overcome the obstacles to routine use of EEG in emergency departments (EDs).

METHODS

The microEEG was used to obtain EEGs from healthy volunteers in the EEG laboratory and ED. The standard system was used to obtain EEGs from healthy volunteers in the EEG laboratory, and studies recorded from patients in the ED or ICU were also used for comparison. In one experiment, a signal splitter was used to record simultaneous microEEG and standard EEG from the same electrodes.

RESULTS

EEG signal analysis techniques indicated good agreement between microEEG and the standard system in 66 EEGs recorded in the EEG laboratory and the ED. In the simultaneous recording the microEEG and standard system signals differed only in a smaller amount of 60 Hz noise in the microEEG signal. In a blinded review by a board-certified clinical neurophysiologist, differences in technical quality or interpretability were insignificant between standard recordings in the EEG laboratory and microEEG recordings from standard or electrode cap electrodes in the ED or EEG laboratory. The microEEG data recording characteristics such as analog-to-digital conversion resolution (16 bits), input impedance (>100MΩ), and common-mode rejection ratio (85 dB) are similar to those of commercially available systems, although the microEEG is many times smaller (88 g and 9.4 × 4.4 × 3.8 cm).

CONCLUSIONS

Our results suggest that the technical qualities of microEEG are non-inferior to a standard commercially available EEG recording device. EEG in the ED is an unmet medical need due to space and time constraints, high levels of ambient electrical noise, and the cost of 24/7 EEG technologist availability. This study suggests that using microEEG with an electrode cap that can be applied easily and quickly can surmount these obstacles without compromising technical quality.

Evaluation of a Novel EEG Preamplifier

SUMMARY

The authors performed initial clinical testing of a novel EEG transduction module (ETM), designed to record EEG signals from electrodes with high and unbalanced contact impedances. Twenty patients underwent two consecutive EEG studies. In the first, "experimental" study, electrodes were applied to an unprepared scalp, and the ETM performed initial signal transduction and pre-amplification. The second, "routine" EEG was acquired in the standard manner, with electrode contact impedances of 5 k Omega or less. Power spectral analysis was performed on all electrode signals from three experimental studies, and all studies were interpreted by three board-certified electro-encephalographers. Individual electrode impedances in the experimental studies ranged from 10 to 560 k Omega (mean 129 k Omega). Power spectra on 54 of 57 electrode signals analyzed were free of 60-Hz noise. The majority of experimental studies were technically adequate, and technical limitations were unrelated to the ETM. Interrater reliability of preparation-free and standard EEG interpretation was high. The ETM device is an effective "preparation-free" technology in the setting of a clinical EEG laboratory. It provided easily interpretable EEG signals free of 60-Hz noise, recorded from electrodes with high and unbalanced impedances placed on completely unprepared scalp with minimal electrode paste.

Mechanisms of intraoperative brainstem auditory evoked potential changes

Brainstem auditory evoked potential (BAEP) changes during intraoperative monitoring may reflect damage to or potentially reversible dysfunction of the ear, the eighth nerve, or the brainstem auditory pathways up to the level of the mesencephalon. They may also be caused by other physiologic mechanisms such as anesthesia, hypothermia, and acoustic masking from drilling noise, or they may result from technical factors that prevent proper stimulus delivery or recording of an evoked potential that is actually present. Cochlear ischemia or infarction resulting from compromise of the internal auditory artery and inner ear damage during temporal bone drilling will affect all BAEP components, including wave I. Direct mechanical or thermal trauma to the eighth nerve will delay, attenuate, and possibly eliminate waves III and V, but wave I, which is generated at the cochlear end of the eighth nerve, may be preserved. During scraping of tumor off the eighth nerve, force applied in an ear-toward-brainstem direction can avulse the fragile fibers of the distal eighth nerve at the area cribrosa. Prolonging the I-to-III interpeak interval during retraction of the cerebellum and brainstem reflects stretching of the eighth nerve, and is often reversible. Vasospasm within the eighth nerve can cause similar, potentially reversible BAEP changes. Damage to the brainstem auditory pathways at or below the level of the mesencephalon will delay and attenuate or eliminate wave V. Wave III is affected similarly if the damage is at or caudal to the region of the superior olivary complex. These BAEP changes may reflect direct mechanical or thermal damage to the brainstem, brainstem compression, or ischemia or infarction resulting from vascular compromise. During BAEP monitoring, examination of the pattern of BAEP changes, analysis of their correlation with surgical maneuvers, and investigation for possible contributory technical factors can help to determine the cause of the BAEP changes and provide the appropriate information to the rest of the surgical team.